Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.
PsyArXiv May 14, 2026 preprint DOI: 10.31234/osf.io/3b9fx_v1
Summary
The study protocol outlines a double-blind randomized controlled trial investigating the use of low doses of psilocybin combined with virtual reality exposure therapy for treating social anxiety disorder. The aim is to assess whether this combination can effectively reduce symptoms of social anxiety compared to standard treatment methods. The specific outcomes and metrics will be evaluated during the trial.
Study at a glance
| Design | double-blind randomized controlled trial |
|---|---|
| Population | individuals with social anxiety disorder |
Abstract
Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.